Pharmacopeia, Inc.
![]() | This article does not cite any sources. (September 2011) |
Pharmacopeia was a public biotechnology company that pioneered the field of small molecule combinatorial chemistry.
Pharmacopeia was founded by Larry Bock and Drs. Michael Wigler, Clark Still and Jack Chabala.
Pharmacopeia went public in 1996 and was acquired by Ligand Pharmaceuticals on December 13, 2008.
References[]
External links[]
- Historical business data for Pharmacopeia, Inc.:
- SEC filings
Categories:
- Biotechnology companies of the United States
- 1996 initial public offerings
- 2008 mergers and acquisitions